← SynDRA
PINDOLOL
SynDRA canonical compound SYN0000475 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR1A |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- ADRB1
- ADRB2
- HTR1A
- HTR2A
- HTR2B
- ADRB3
- HTR1B
- HTR1D
- HTR2C
- Htr1a
- Htr1b
- Htr1d
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 PARTIAL AGONIST
- Beta-1 adrenergic receptor partial agonist
- ADRB2 PARTIAL AGONIST
- Beta-2 adrenergic receptor partial agonist
- HTR1A ANTAGONIST
- HTR2A FULL AGONIST
- HTR2A ANTAGONIST
- HTR2B FULL AGONIST
- HTR2B ANTAGONIST
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- OPRK1
- TMEM97
- SLC22A1
- DRD4
- DRD3
- NPY1R
- NPY2R
- ADRA1A
- HTR1E
- HTR5A
- OGG1
- NR3C1
- NR1I2
- MPG
- NFKB1
- NEIL2
- NEIL1
- OPRD1
- MUTYH
- MPHOSPH8
- ACHE
- MMP9
- OPRM1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- KCNH2
- HTR7
- HTR6
- MMP1
- PDE5A
- PDE3A
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT1A
- 5HT2A
- 5HT2B
- AGAL
- CP2D6
- CP3A7
- MDR1
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Serotonin Agents
- Serotonin Antagonists
- Vasodilator Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND OTHER DIURETICS
Cross-references
Synonyms
- VISKAZIDE
- VISKEN
- betapindol
- pinbetol
- prinodolol
- dl-Pindolol
- durapindol
- LB-46
- (rs)-pindolol
- Apo-pindol
- Betapindol
- Blocklin-l
- Calvisken
- Carvisken
- Decreten
- Dl-lb-46
- Dl-pindolol
- Durapindol
- Glauco-visken
- Pectobloc
- Pinbetol
- Prinodolol
- Pynastin
- (+/-)-LB-46
- NSC-757276
- Betadren
- Pindolol component of viskazide
- Visken
- Blocklin
- Pindololum
- Prindolol
- Blockin L
- Blocklin-L
- LB46
- P 0778
- Betapindol (TN)
- Blockin L (TN)
Reported adverse events
- Dizziness
- Fatigue
- Hallucination
- Insomnia
- Nausea
- Nervousness
- Palpitations
- Pruritus
- Rash
- Agranulocytosis
- Peyronie's disease
Look up PINDOLOL in the interactive SynDRA portal →